Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 27, 2021

SELL
$11.24 - $21.0 $911,193 - $1.7 Million
-81,067 Closed
0 $0
Q2 2021

Jul 23, 2021

BUY
$18.04 - $22.09 $530,538 - $649,644
29,409 Added 56.93%
81,067 $2.59 Million
Q1 2021

Apr 27, 2021

BUY
$16.59 - $33.89 $119,846 - $244,821
7,224 Added 16.26%
51,658 $1.56 Million
Q4 2020

Feb 03, 2021

SELL
$27.5 - $37.92 $65,587 - $90,439
-2,385 Reduced 5.09%
44,434 $1.92 Million
Q3 2020

Oct 27, 2020

BUY
$34.44 - $43.75 $244,110 - $310,100
7,088 Added 17.84%
46,819 $2.53 Million
Q2 2020

Aug 04, 2020

SELL
$27.12 - $45.97 $55,487 - $94,054
-2,046 Reduced 4.9%
39,731 $2.43 Million
Q4 2019

Jan 31, 2020

SELL
$46.96 - $61.67 $62,128 - $81,589
-1,323 Reduced 3.07%
41,777 $3.67 Million
Q3 2019

Oct 23, 2019

BUY
$59.47 - $93.1 $2.56 Million - $4.01 Million
43,100 New
43,100 $3.96 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $605M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.